MétaCan
Menu
Back to cohort
Record W4411648053 · doi:10.1101/2025.06.24.25330200

Pharmacometric evaluation of amodiaquine-sulfadoxine-pyrimethamine and dihydroartemisinin-piperaquine seasonal malaria chemoprevention in northern Uganda

2025· preprint· en· W4411648053 on OpenAlexfundno aff
Craig Bonnington, Anthony Nuwa, Katherine Theiss-Nyland, Richard Kajubi, Moses R. Kamya, Joaniter I. Nankabirwa, Chris Ebong, Christian Rassi, Jane Nabakooza, Jimmy Opigo, David Salandindi, Musa Odongo, Chayanin Sararat, James A Watson, Kanokon Suwannasin, Stéphane Proux, Urairat Keosukwiwat, Joel Tärning, Mallika Imwong, James Tibenderana, François Nosten, Nicholas J. White

Bibliographic record

VenuemedRxiv · 2025
Typepreprint
Languageen
FieldMedicine
TopicMalaria Research and Control
Canadian institutionsnot available
FundersMinistry of Health, UgandaInternational Development Research CentreWellcome TrustBill and Melinda Gates Foundation
KeywordsAmodiaquinePiperaquineMalariaDihydroartemisininSulfadoxine/pyrimethamineSulfadoxineMedicineHalofantrinePyrimethamineMefloquineChloroquineArtemisininPlasmodium falciparumImmunology

Abstract

fetched live from OpenAlex

Abstract Background Seasonal malaria chemoprevention (SMC) using monthly amodiaquine-sulfadoxine-pyrimethamine (SPAQ) is being deployed East Africa, where antimalarial drug resistance levels are high. Dihydroartemisinin-piperaquine (DP) is a potential alternative. Methods A 28 day pharmacometric assessment of SMC was conducted in Karamoja, Northern Uganda. In two villages children received SPAQ and in one, either DP or no SMC. The primary outcome was malaria infection (all species) defined by capillary blood sample qPCR positivity on day 28, or new slide or rapid diagnostic test positivity after day 2. Results Baseline qPCR malaria parasitemia prevalence among 1250 enrolled children was 46% (575/1250); P. falciparum 85%, other malarias (mainly P. ovale ) 25%. Breakthrough parasitemias occurred in 7% (33/496) of DP, 31% (158/504) of SPAQ, and 39% (98/250) of no drug recipients. Clinical malaria (all P. falciparum ) developed in 17% of no drug (42/250; 1 severe), 8% of SPAQ (38/504; 2 severe) and 2% of DP (13/496) recipients. Adjusted protective efficacies against all malaria, all clinical malaria and all falciparum malaria were SPAQ; 56% (95%CI 35-70%), 60% (27-78%), and 46% (11-68%), and for DP; 84% (77-89%), 86% (74-92%) and 86% (75-92%) respectively. Some asymptomatic P. falciparum infections were not cleared by SPAQ. All 260 P. falciparum isolates genotyped were Pfcrt K76 (haplotype CVMNK, a marker of 4-aminoquinoline susceptibility) and most were quintuple Pf dhfr/dhps mutants (i.e. relatively SP resistant). The chemoprevention drug exposure-response relationship was strong for desethylamodiaquine, but weak for sulfadoxine. Conclusions SPAQ SMC had low clinical and parasitological chemopreventive efficacy in Northern Uganda whereas dihydroartemisinin-piperaquine was effective. Funding Bill & Melinda Gates Foundation; GiveWell; Wellcome. The Infectious Diseases Research Collaboration (IDRC) and Malaria consortium received funds from grant Investment IDs INV-043830 and INV-039889 - Uganda SMC and CPES Phase 2 from the Gates Foundation. The findings and conclusions contained within are those of the authors and do not necessarily reflect positions or policies of the Gates Foundation. NJW is a Principal Research Fellow funded by the Wellcome Trust (093956/Z/10/C). JAW is a Sir Henry Dale Fellow funded by the Wellcome Trust (223253/Z/21/Z). Clinical Trials registration NCT05323721

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.005

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.036
GPT teacher head0.352
Teacher spread0.316 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venuemedRxivSame topicMalaria Research and ControlFrench-language works237,207